The Environmental Mutagenesis and Genomics Society (EMGS) invites members of the toxicology community to join its 57th Annual Meeting, taking place virtually on October 12–14, 2026. Centered on the theme, “Advancing Exposure Science: From Mechanisms to Risk,” this meeting highlights the science shaping modern approaches to genotoxicity testing, risk assessment, and public health protection.
The program connects mechanistic biology with real-world application, showcasing how advances in DNA damage and repair, mutagenesis, epigenetics, and toxicogenomics are being translated into more predictive, human-relevant safety assessments.
Attendees will gain practical insight into the use of next-generation sequencing, new approach methodologies (NAMs), and integrated omics to refine testing strategies, strengthen weight-of-evidence approaches, and reduce uncertainty in regulatory decision-making.
The meeting features:
Eight symposia covering topics such as NAMs in regulatory application, nitrosamine mutagenicity beyond hazard identification, developmental and multigenerational effects, and sex-specific responses to mutagens
Platform and poster sessions highlighting advances in genetic toxicology, exposure science, and risk assessment
Two internationally recognized keynote speakers, Dr. Chris Mason (Cornell University) and Dr. Allan Balmain (University of California, San Francisco), offering insights into genomics, cancer biology, and the future of translational science
Designed to foster cross-disciplinary exchange, EMGS 2026 provides actionable insights to support science-based decision-making and advance protection of human health and the environment.